Plain-English translation of NCT07648888 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial compares two minimally invasive treatments for an enlarged prostate that causes urinary problems. One treatment, called Rezum, uses heated water vapor to shrink prostate tissue. The other is a surgical technique that carefully removes excess prostate tissue while trying to protect the structures involved in ejaculation. Both approaches aim to improve urinary symptoms while keeping sexual function intact—something that matters a lot to sexually active men.
Enlarged prostate is very common in older men and can seriously affect quality of life, sleep, and sexual health. Many existing treatments work well for urinary symptoms but can damage ejaculation. This trial exists to find out whether these two newer approaches can solve the urinary problem while better preserving normal ejaculation.
You likely qualify if…
You likely don't qualify if…
You will have baseline tests including blood work, urine tests, imaging, and questionnaires about your urinary and sexual symptoms. Then you and your surgeon will together decide which of the two treatments feels right for you based on a detailed discussion of benefits, risks, and recovery. After your chosen treatment, you will return for follow-up visits to complete the same symptom questionnaires and have testing to measure how well the treatment worked and whether your sexual function was preserved.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
Egypt